IntegraGen Logo

IntegraGen

Genomic analysis & molecular diagnostics for cancer and rare diseases for researchers and labs.

ALINT | PA

Overview

Corporate Details

ISIN(s):
FR0010908723
LEI:
969500CQD8K0BUIGDH55
Country:
France
Address:
5 RUE HENRI DESBRUERES, 91000 EVRY-COURCOURONNES
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

IntegraGen, an OncoDNA group company, specializes in the genomics of cancer and rare genetic diseases. The company's mission is to translate molecular research into clinical practice through the development and commercialization of molecular diagnostic tests derived from the identification of genetic biomarkers. It provides expert genomic analysis and interpretable data services to academic researchers, private laboratories, and other life sciences organizations, aiming to advance both research and patient care.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-29 17:45
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 352.0 KB
2025-10-06 18:30
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 238.4 KB
2025-04-29 18:00
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 351.8 KB
2025-04-29 18:00
Earnings Release
Inside Information / News release on accounts, results
English 356.4 KB
2025-01-15 18:44
Earnings Release
Inside Information / Information on annual revenues
English 214.4 KB
2025-01-15 18:44
Earnings Release
Informations privilégiées / Information sur chiffre d’affaires annuel
French 215.6 KB
2024-10-17 18:29
Earnings Release
Inside Information / News release on accounts, results
English 343.2 KB
2024-10-17 18:29
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 398.7 KB
2024-07-18 18:44
Earnings Release
Inside Information / Other news releases
English 270.7 KB
2024-07-18 18:44
Earnings Release
Informations privilégiées / Autres communiqués
French 268.3 KB
2024-04-18 18:00
Earnings Release
Inside Information / News release on accounts, results
English 372.7 KB
2024-04-18 18:00
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 419.4 KB
2024-01-16 17:45
Earnings Release
Inside Information / Information on annual revenues
English 307.9 KB
2024-01-16 17:45
Earnings Release
Informations privilégiées / Information sur chiffre d’affaires annuel
French 269.3 KB
2023-10-19 18:15
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 332.6 KB

Automate Your Workflow. Get a real-time feed of all IntegraGen filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IntegraGen

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IntegraGen via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Oryzon Genomics S.A. Logo
Develops epigenetic-based medicines for cancer and central nervous system disorders.
Spain ORY
OSCOTECInc. Logo
A clinical-stage drug discovery company developing innovative medicines for unmet needs.
South Korea 039200
OSE Immunotherapeutics Logo
Develops first-in-class immune therapies for oncology and inflammation, partnering for late-stage.
France OSE
Oxurion NV Logo
Acquires European pharmaceutical subcontractors to build an integrated healthcare services group.
Belgium OXUR
PA Co., Ltd Logo
Offers HR solutions like recruitment media, staffing, and childcare to revitalize local communities.
Japan 4766
Passage BIO, Inc. Logo
Developing genetic medicines for severe CNS and neurodegenerative disorders.
United States of America PASG
PCI Biotech Holding Logo
Biopharma firm evaluating its future after discontinuing its core technology development.
Norway PCIB
PC İLETİŞİM VE MEDYA HİZMETLERİ SANAYİ TİCARET A.Ş. Logo
Integrated media group providing data-driven advertising and media solutions for global brands.
Türkiye PCILT
PDS Biotechnology Corp Logo
Developing T-cell activating immunotherapies for cancer and infectious diseases.
United States of America PDSB
Peers Co.,Ltd. Logo
Accelerating tech adoption with consulting, HR services, and proprietary IT/AI solutions.
Japan 7066

Talk to a Data Expert

Have a question? We'll get back to you promptly.